NCT06534762
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
- Locations
-
- Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
Clinical trial condition
Histiocytic Disorders, Malignant
Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.
271 public trials
44 recruiting studies
Histiocytic Disorders, Malignant trial results
NCT06526065
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Universitätsmedizin Göttingen Göttingen, Lower Saxony, Germany
NCT06287398
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
- Locations
-
- Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Incyte Biosciences Italy S.r.l Milan, Italy
NCT07819396
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +52 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Not yet recruiting
Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement
NCT07812493
- Conditions
- CNS Involvement of Systemic Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT07443137
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +5 more
- Locations
-
Not specified
Not yet recruiting
Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma
NCT07744750
- Conditions
- CLL / SLL, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Not yet recruiting
Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
NCT07744737
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Not yet recruiting
Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
NCT07744724
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China